PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIAS
Auricular Tachycardia This is the most common of all paroxysmal tachycardias and occurs most often in individuals who are free from structural heart disease. In such patients the paroxysms are usually of short duration and require little or no therapy. Despite the benign nature of these episodes, medical help is not infrequently sought, especially during the initial attacks, or for paroxysms which do not respond to simple measures which most patients learn to use after experiencing repeated attacks. Among the latter are the Valsalva procedure of attempted forced expiration with the glottis shut, prolonged holding of the breath, compression of the neck, and the assumption of various positions, such as lowering the head over the side of a couch, or twisting the head in extreme rotation to either side. Lastly, patients often induce vomiting by mechanical irritation of the pharynx or by drinking mustard diluted in water.
Although death is uncommon in adults during auricular paroxysmal tachycardia, even when organic heart disease is present, serious complications, including heart failure, may occasionally ensue. In infants and young children, however, heart failure and death may occur inl the absence of recognizable heart disease. Wheti structural heart disease is present, symptoms including dyspnea, substernal pain, vertigo and syncope may result. Persistence of this rapid arrhythmia may produce heart failure. Inl such circumstances it is imperative that the impaired heart be spared the excessive burden of the tachycardia by abolishing the abnormal mechanism as soon as possible. Since most patients with paroxysmal tachycardia suffer from considerable apprehension during an attack, especially during the initial episodes, a sedative in the form of a rapidly acting barbiturate should be administered as promptly as possible. The patient should be placed at rest and reassured of the innio(ence of the attack. These measures alone xvill frequently produce reversion to normal rhythm.
Cir(clation, Vltume IV, November, 1.951 iMANAGEMENT OF ACUTE CARDIAC EMERGENCIES As a rule morphine and other opiates are contraindicated because of the danger of possible habituation. This is particularly true if the patient does not have underlying heart disease. If the paroxysm still persists then other methods of therapy should be used. Among these are several physical procedures. Carotid sinus pressure is the one most often tried, and probably the most successful in abolishing paroxysmal tachycardia of auricular and nodal origin. Carotid pressure is most likely to be effective if the sinuses are massaged, trying first the right and then the left. This is best performed by pressing against the carotid sinus at the angle of the jaw, compressing the carotid posteriorly and medially against the vertebral bodies. Considerable pressure in the massaging is required. If this measure is not successful before medication, it is frequently effective in converting supraventricular tachycardias after the patient has been treated with one of the drugs which produce vagal stimulation. The latter include the digitalis substances and Mecholyl. Their uses will be (lescribed below. Ocular pressure is also a physical measure to produce vagal stimulation. It is not as effective and apparently is now less often used than carotid sinus massage. Occasionally damage to the eye may result from this treatment.
Although quinidine still seems to be the drug preferred by many clinicians to terminate auricular and nodal paroxysmal tachycardias, one of the rapidly acting glycosides of digitalis is being used more frequently as the drug of choice.1 In infants and young children who become critically ill in the presence of auricular paroxysmal tachycardias, intravenous administration of a digitalis preparation is not only effective but may actually be life-saving. Digitalis may be given by mouth in the usual digitalizing dosage if there is no urgency.
Ouabain, given intravenously, is probably the best preparation for the rapid conversion of auricular or nodal paroxysmal tachycardia.
There is danger in employing this, or any other digitalis preparation, if the patient has received digitalis within the previous two weeks. The initial dose for adults is 0.5 mg. followed every hour by 0.1 mg. until the paroxysm ceases or a total of 1.0 mg. has been administered. MIost patients obtain full therapeutic effect with 0.8 mg. of ouabain.
If ouabain is not available, lanatoside C (Cedilanid) may be administered intravenously.2 The initial dose is 0.8 mg., followed by 0.4 mg. if no favorable response is obtained in one hour. The majority of patients will respond to the initial dose of 0.8 mg. However, a total of 1.6 mg. of lanatoside C may be required. Digoxin,3 also given intravenously, is another preparation which may be employed for rapid digitalization in the management of auricular and nodal paroxysmal tachyeardias. When administered intravenously the introductory dose of 0.5 mg. is followed every two hours by 0.25 mg. until full effect is obtained, or until a total of 1.5 mg. has been given. As with paroxysmal tachycardia, the initial treatment should include physical and mental rest obtained by means of a sedative, preferably a barbituric acid derivative. Morphine may be required in those patients waith organic heart disease in whom heart failure may be precipitated by the arrhythmia.
Quinidine is usually effective in converting paroxysmal auricular fibrillation to normal sinus rhythm, and is considered by most clinicians to be the drug of In most cases of auricular flutter the patient is aware of the disturbance but is commonly in no great distress. However, heart failure may be present or may ensue, especially where the ventricular rate is rapid. While auricular flutter will occasionally respond to quinidine or to procaine amide, it is probably advisable to digitalize all patients with paroxysmal auricular flutter as soon as the arrhythmia is recognized. This is indicated particularly when there is 9i rapid ventricular rate, or when conigestive failure is present or impending.
If flutter should occur in a patient Ad ithi a recent myocardial infarct, and digitalis or quinidine is to be used, it is not necessary to employ anticoagulant therapy, as when auricular fibrillation occurs following infarction, since embolism rarely if ever takes place during flutter.7
When acute heart failure is associated with flutter, ouabain, lanatoside C, or Digoxin should be given intravenously, provided the patient has not received a digitalis preparation during the previous 14 days. If heart failure is not present or is of mild degree, digitalization may be accomplished orally over a period of a day or so, using the whole leaf of digitalis, or whatever glycoside the clinician prefers. Digitalis therapy usually results in one of the following eventualities: the flutter may be converted to fibrillation and remain as such; fibrillation may then be converted to normal sinus rhythm with quinidine, usually after digitalis has first been discontinued; fibrillation may revert to sinus rhythm spontaneously after withdrawal of digitalis without the necessity of using quinidine; or flutter may persist despite digitalization. In the latter instance, quinidine should be tried, as described under treatment of auricular tachycardia.
VENTRICULAR TACHYCARDIA Ventricular tachycardia occurs, as a rule, in the presence of various structural changes in the heart, especially during the course of myocardial infarction. It is one of the most serious complications which may occur following infarction. Occasionally it is caused by digitalis intoxication, particularly in a patient with a seriously impaired myocardium. Uncommonly it occurs in a normal heart.
The presence of this arrhythmia should be suspected in any patient with heart disease who has a sudden change of heart rate to 160 to 200 or more beats per minute and which is basically regular in rhythm. It is well to remember that it can occur in complete heart block and that it may lead to bouts of ventricular fibrillation which, with ventricular tachycardia, may be a cause of Adams-Stokes seizures.
It is imperative that this rhythmic disturb- Preliminary observations of our own and others indicate that procaine amide is also effective in the treatment of supraventricular arrhythmias. These include paroxysmal auricular and nodal tachyeardias, auricular fibrillation, and auricular flutter. Procaine amide may be used as a substitute for quinidine; it may be tried in cases where quinidine treatment has been unsuccessful, or where there is intolerance to the latter drug. Like quinidine, procaine amide appears to be least effective when the arrhythmia has been of long standing.
Procaine amide may be employed both orally and intravenously; the latter route has been observed to cause a marked though transient fall in blood pressure. Nausea and vomiting have been noted occasionally as side effects but only where large doses are given orally. Clinical experience to date indicates procaine amide may be less toxic and more effective than quinidine in ventricular tachycardia. Evidence suggests that it is less dangerous whenl given intravenously than quinidine given by the same route. The dosage recommended for the administration of procaine amide is necessarily provisional at this time because of the limited number of cases which have been studied. grams, preferably with a direct-writing instrument, during intravenous administration. Procaine amide appears to have a quinidine-like action uponi the heart. The toxic effects seen on the electrocardiogram are very similar to those of quinidine. They include prolongation of QRS and the Q-T interval and decrease in voltage. Rarely, ventricular tachycardia and ventricular fibrillation have resulted from procaine amide apparently because of too rapid administration or intravenous dosage in excess of 1 Gm.
In the treatment of ventricular tachyeardias this new drug may make unnecessary trial with less effective agents, including magnesium sulfate, potassium chloride or Paredrine hydrobromide.
Although digitalis and its glycosides may, in toxic doses, produce ventricular tachycardia, the number of instances in which this occurs is probably small. The use of digitalis in the presence of ventricular tachycardia following myocardial infarction has recently been reviewed.12 Symptoms, which could have been interpreted as being due to digitalis intoxication in three patients with ventricular tachycardia and heart failure, disappeared in spite of the continued use of digitalis. The conclusions seem to indicate that digitalis may be used safely in the treatment of ventricular tachycardia when congestive heart failure is present. However, Ihis requires further investigation before it can be completely accepted. COMPLETE If an Adams-Stokes seizure is the result of asystole of the ventricles, epinephrine, 1 cc.
(1:1000 dilution), is the drug to be used. It should be administered by injection into the heart. This may be followed by ephedrine sulfate, 25 mg. subcutaneously every four hours. If ventricular standstill continues, Paredrine hydrobromidel3 should be tried, also by injection into the heart. If cardiac standstill should occur while a patient is undergoing an operation, manual massage of the heart or direct electric stimulation of the ventricles of the exposed heart should be performed. '4 If congestive heart failure occurs in the presence of complete heart block, digitalis should be administered. There is no contraindication to its use in this condition unless, of course, the arrhythmia is the result of digitalis intoxication.
CONGESTIVE HEART FAILURE This condition is not infrequently an emergency in those instances where failure has appeared rapidly, or when a patient in congestive heart failure is in need of immediate surgical or obstetric care. Regardless of the type of heart disease, the basic principles of treatment are much the same. Management should be modified by the nature of the precipitating cause of the congestive heart failure. For example, if a myocardial infarct has induced heart failure it is considered advisable to use anticoagulant therapy, as well as such drugs as digitalis or one of its glycosides.
The greatest immediate benefit is accomplished by reducing the excessive burden carried by the impaired heart. This can be done by placing the patient at complete rest but not necessarily confined to bed. If there is considerable anxiety or pain, morphine should be administered subcutaneously or intravenously.
If there is no contraindication, particularly the use of digitalis within the previous two weeks, ouabain, Digoxin, or any rapidly acting digitalis preparation should be given intravenously, regardless of the heart rhythm. The initial dose of ouabain should be 0.5 mg., repeating 0.1 mg. every half to one hour or until therapeutic effect has been obtained, for a total of not more than 1 mg. Digoxin may be given with an initial dose of 0.5 mg., intravenously, CLINICAL PIROGRESS followed by 0.25 mg. every four hours until a favorable response or a maximum of 1.5 mg. have been given. When using lanatoside C intravenously the first dose is 0.8 mg. followed by 0.4 mg. every two hours if needed to obtain a therapeutic response. Total dosage should generally not exceed 2.4 mg.
ACUTE,LEFT VENTRICULAR FAILURE
This emergency occurs most commonly in patients with the hypertensive type of heart disease. Left ventricular failure may occur also during or after operation, particularly if saline infusions or transfusions have been administered rapidly or in large quantity to a patient with structural heart disease. The prominent symptom is paroxysmal dyspnea; cough is also common. This initial phase may progress to pulmonary edema; then there is often expectoration of pink, frothy, watery sputum which may be raised in mouthfuls.
Morphine sulfate, 15 liters of oxygen a minute must be employed in order to maintain this concentration. Unfortunately, mouth breathing, which is quite prevalent, lowers the oxygen percentage in the air inhaled.
If the patient has not had any digitalis iii the previous two weeks, ouabain, lanatoside C, Digoxin, or any other rapidly acting preparation, should be given intravenously. The dosage to be used has been described. However, if the patient is to undergo an emergency procedure such as an operation or an obstetric delivery, it is advisable to supplement and maintain the effects produced by a rapidly dissipated parenteral glycoside with the simultaneous administration of an oral digitalis preparation.' One advantage of this procedure is that rapid and complete digitalization is accomplished within 6 to 12 hours. The other is that it dispenses with the necessity of administering a digitalis preparation at repeated intervals during the first 24 hours. By this method, maintenance dosage may be started 24, or if necessary, 48 hours after initial digitalization which is performed as follows: a single dose of one of the rapidly acting glycosides is given parenterally. Simultaneously, a dose of one of the more slowly acting digitalis preparations is given orally, in a dosage depending on the estimated weight of the patient. Experience with this procedure has been most satisfactory, employing ouabain in a dose of 0.5 Gm., intravenously, and the whole leaf tablet of digitalis (New York Heart Association Preparation, U.S.P. XIII) They are particularly useful in that they can be used by the patient at the onset of a bout of paroxysmal dyspnea and sometimes lessen the severity of the attack.
"Bloodless phlebotomy" may be anl effective adjunct to treatment if pulmonary edema is accompanied by venous engorgement. The purpose of this procedure is to utilize the peripheral venous system as a reservoir, decrease the circulating blood volume, and thereby diminish the venous return to the heart. It is accomplished by applying tourniquets, preferably blood pressure cuffs, to all four extremities. Three of the cuffs are inflated at a time to a pressure slightly higher than the level of the patient's diastolic pressure. Release of each cuff is done in rotation every fifteen minutes to permit re-establishment of adequate blood flow. If this, and the measures outlined above, have not been successful in relieving the acute failure, phlebotomy, with the rapid withdrawal of at least 500 cc. of blood, should be performed.
Since the maintenance of an edema-free state is important, particularly in paroxysmal dyspnea or pulmonary edema, a mercurial diuretic should be administered intramuscularly or subcutaneously shortly after the measures described above have been initiated. A new mercurial diuretic, Thiomerin, which may be administered subcutaneously, intramuscularly, or intravenously, has been employed with excellent results.'7 18 Based on ease of administration, degree of diuresis, and local tolerance, it is now considered by many to be the diuretic of choice. The fall in blood pressure, which is often noted as part of a coronary attack, does not of itself constitute shock, even when systolic pressures of 90 mm. Hg or lower are present. Congestive failure, which not uncommonly occurs as a consequence of myocardial infarction, and which may be present concomitantly, should also not be confused with this condition.
Shock is identified by the following characteristic findings: The patient may be restless and apprehensive but he is more often in a semicomatose or comatose state. There is extreme pallor or cyanosis and the skin is cold and moist. The peripheral pulses are weak, thready or undetectable. The systolic pressure is usually 90 mm. Hg, or lower, and the pulse pressure is small; in patients who have previously manifested hypertension, the systolic pressure may be considerably higher than this figure.
Therapy should be based upon an understanding of the pathologic physiology which is responsible for -the condition. Unfortunately, fundamental data concerning these mechanisms are inadequate and incomplete. There remains considerable controversy as to whether the primary mechanisms are cardiogenic or due to factors related to the vascular system. Because this process is not completely understood, plans of management of shock following myocardial infarction vary from the practice of "judicious neglect" to the use of a conglomeration of drugs and procedures based upon varied theoretic concepts. 21 indicate that, while intravenous transfusions are not as yet of proved value, they have usually resulted in at least transient improvement. Where the treatment has failed it has appeared that larger, more frequent, or more rapidly administered transfusions might have reversed the shock picture or prevented recurrence. It has also been noted rather surprisingly that heart failure has rarely been produced by transfusions employed in this condition. Occasionally, indeed, where some degree of failure has been present at the time the transfusion was started, the signs have cleared following treatment. On the basis of experience thus far, it appears that the use of transfusions following myocardial infarction is only definitely contraindicated when a high venous pressure, or marked pulmonary edema, is present.
Experimental studies22 and preliminary clinical trials23' 24 indicate that intra-arterial transfusions may be superior to intravenous transfusions in the treatment of this type of shock. Theoretic advantages of the intra-arterial, as compared with the intravenous route, are that intra-arterial transfusions effect a more prompt increase in blood pressure and probably of circulating blood volume. Consequently, there should be less danger of immediate overloading of the heart than with the use of larger intravenous transfusions. Experimental work on dogs in shock22 has shown rapid retrograde perfusion of renal, coronary and cerebral arteries following arterial transfusion. In view of these considerations the use of intra-arterial transfusions of blood or plasma in the treatment of "coronary shock" warrants further investigation and evaluation.
SHOCK FOLLOWING PULMONARY EMBOLISM Another form of shock which may be considered a cardiac emergency is that which frequently follows pulmonary embolism. Pulmonary emboli usually come from thrombi in the deep veins of the lower extremities or from the veins of the pelvis in surgical and obstetric patients. Symptoms are variable but in typical cases the patient suddenly becomes acutely dyspneic and cyanotic, is restless and anxious, complains of severe substernal oppression, and often there is rapid progress to shock and death. Differential diagnosis between pulmonary embolism and acute myocardial infarction may be difficult. History, x-ray, and especially the electrocardiogram are helpful in the diagnosis. Unfortunately, myocardial infarction is known to occur secondary to pulmonary embolism, in which circumstance evidences of both conditions will coexist. Prognosis of pulmonary embolism depends chiefly upon the size of the embolus, the severity of secondary reflex effects, and the promptness with which treatment directed at the relief of these factors is instituted.
In the treatment of this condition, oxygen should be given as soon as available. Morphine, combined with atropine, is administered if the patient is acutely dyspneic and is suffering from pain or anxiety. Vasodilator Acute tamponade of the heart may occur following injury to the heart, to the pericardium, or to the great vessels. It results commonly from stab or gunshot wounds, but it may also complicate infections of the pericardium if there is considerable effusion. This is especially liable to occur in acute suppurative pericarditis. Rare, and invariably fatal, causes of tamponade are rupture of the heart following myocardial infarction, and retrograde progression of a so-called dissecting aneurysm of the aorta.
Patients with wounds and tamponade of the heart may be restless or in profound shock when first seen. The pulse is usually weak, thready, or imperceptible. Classically it is paradoxical in type. The blood pressure is commonly very low or unobtainable. The veins of the neck are distended. Heart sounds are generally distant or inaudible.
In the treatment of this condition aspiration of the pericardial space is usually indicated as an emergency measure to relieve tamponade. Early aspiration is also necessary because this blood clots rather rapidly and can be easily removed only soon after bleeding occurs. Fortunately, in many instances the bleeding does not recur and subsequent operation is not neces- An aid in therapy which may help to prevent circulatory failure in acute pericardial tamponade is the rapid administration of intravenous infusions of saline, or of other intravenous solutions.26' 27 The increase in venous pressure produced by this means will frequently overcome the resistance to the return of the blood to the right heart caused by tamponade. This increase may be sufficient to permit improvement in cardiac filling, and therefore of cardiac output. The result of this treatment is largely dependent upon whether the pericardial sac is able to stretch further. Intravenous infusion alone may aid in maintaining the circulation of the patient with tamponade. At Cardiac tamponade may also result from empyema secondary to acute suppurative pericarditis, or from large effusions such as are found in tuberculous pericarditis. Tamponade due to these causes produces circulatory failure of the same type as that observed in patients with stab wounds of the heart. It is treated by aspiration or by surgery with open drainage if aspiration is inadequate. Penicillin or other antibiotics may be of value when instilled directly into the pericardial sac in suppurative pericarditis following initial aspiration or surgical drainage. This is usually supplemented by systemic antibiotic therapy.
